More focus on patient courses and e.g. analgesic treatment and rehabilitation after surgery might increase the quality of treatment. This was the result of research into accelerated patient courses in 2008. Such research will be given higher priority in the future. Accelerated patient courses are a treatment concept that involves reducing the time of rehabilitation after surgery, thereby reducing the time of hospitalisation so that the patient can return to a normal life more quickly. This field is subject to increasingly more focus, and in 2008 research results showed great benefits from this approach to treatment. Read more...
In 2008 the finishing touches were made to a new research biobank at Rigshospitalet - the biobank is now in operation. The plan is to offer better treatment and establish safer diagnoses in future.In future, excess blood from the many blood tests taken every day at Rigshospitalet will be stored in a new research biobank. The finishing touches to the biobank were made in 2008 to intensify research into DNA and with this better patient management. By storing excess blood from blood tests, researchers at Rigshospitalet will be able to examine genetic variations in large groups of patients, and researchers will be able to tell the significance this may have on patients’ diseases or treatment. This will form the basis for better tailored treatment of patients in future. Read more...
One thing is to have state-of-the-art scanners; another thing is to decode the scan images. Rigshospitalet was one of the first hospitals in Europe to acquire an ultra-fast CT scanner. The hospital is now teaching physicians from all over the world to read scans of the heart.
Measurable effects of prioritised and focussed health and safety initiatives only come after implementation; transforming words into action in daily routines. This is what makes a winner and it is on this basis that Rigshospitalet received the European Good Practice Award in April 2013.
Associate professor Thomas Bjarnsholt has received the Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases from the European Society of Clinical Microbiology and infectious diseases (ESCMID).